Can Statin Prevent the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Disease?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen T
. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2006; 100(12):2724-9.
DOI: 10.1111/j.1572-0241.2005.00287.x.
View
2.
Guruswamy S, Rao C
. Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling. Gene Regul Syst Bio. 2009; 2:163-176.
PMC: 2745153.
DOI: 10.4137/grsb.s486.
View
3.
Samadder N, Mukherjee B, Huang S, Ahn J, Rennert H, Greenson J
. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. Cancer. 2011; 117(8):1640-8.
PMC: 3117060.
DOI: 10.1002/cncr.25731.
View
4.
Liu Y, Tang W, Wang J, Xie L, Li T, He Y
. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies. Cancer Causes Control. 2013; 25(2):237-49.
DOI: 10.1007/s10552-013-0326-6.
View
5.
Lytras T, Nikolopoulos G, Bonovas S
. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies. World J Gastroenterol. 2014; 20(7):1858-70.
PMC: 3930985.
DOI: 10.3748/wjg.v20.i7.1858.
View